Recor Medical, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
5
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 16, 2027The maintenance fee for Ultrasound-Based Neuromodulation System (US 10,350,440) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
- 1 fee due Apr 29, 2027The maintenance fee for Ultrasound-Based Neuromodulation System (US 10,456,605) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 1 fee due Jun 10, 2027The maintenance fee for Ablation Device with Optimized Input Power Profile and Method of Using the Same (US 10,499,937) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,349,928 | Ablation Device and Method of Using the Same In force · Low confidence | In force | Low confidence | |
| US 12,076,033 | Ablation Device with Optimized Input Power Profile and Method of Using the Same In force · High confidence | In force | High confidence | |
| US 8,974,445 | Methods and Apparatus for Treatment of Cardiac Valve Insufficiency In force · High confidence | In force | High confidence | |
| US 10,039,901 | Method and Apparatus for Treatment of Hypertension Through Percutaneous Ultrasound Renal Denervation In force · High confidence | In force | High confidence | |
| US 9,943,666 | Method and Apparatus for Treatment of Hypertension Through Percutaneous Ultrasound Renal Denervation In force · High confidence | In force | High confidence | |
| US 12,274,833 | Method and Apparatus for Treatment of Hypertension Through Percutaneous Ultrasound Renal Denervation In force · High confidence | In force | High confidence | |
| US 11,185,662 | Method and Apparatus for Treatment of Hypertension Through Percutaneous Ultrasound Renal Denervation In force · High confidence | In force | High confidence | |
| US 10,499,937 | Ablation Device with Optimized Input Power Profile and Method of Using the Same In force · High confidence | In force | High confidence | |
| US 9,981,108 | Method and Apparatus for Treatment of Hypertension Through Percutaneous Ultrasound Renal Denervation In force · High confidence | In force | High confidence | |
| US 9,439,598 | Mapping and ablation of nerves within arteries and tissues In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 19: 2 patents in force now held by others · 12 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 2 abandoned · 1 no status recorded